124 Results for "

(7R

" in MedChemExpress (MCE) Product Catalog:
Products (124)

124 Results for "(7R" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-P0049
CAS No.: 113-79-1
Synonyms: Arg8-vasopressin; AVP
Target:  

Vasopressin Receptor

Research Areas:  

Neurological Disease Cancer

Argipressin (Arg8-vasopressin) binds to the V1, V2, V3-vascular arginine vasopressin receptor, with a Kd value of 1.31 nM in A7r5 rat aortic smooth muscle cells for V1.
loading...
    loading...
10
10 Publications Verification
Cat. No.: HY-W539944
CAS No.: 129979-57-3
Synonyms: Arg8-vasopressin acetate; AVP acetate
Research Areas:  

Neurological Disease Cancer

Argipressin (Arg8-vasopressin) (acetate) binds to the V1, V2, V3-vascular arginine vasopressin receptor, with a Kd value of 1.31 nM in A7r5 rat aortic smooth muscle cells for V1 .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-D0014
CAS No.: 6104-58-1
Brilliant Blue G-250 is a dye commonly used for the visualization of proteins separated by SDS-PAGE, offering a simple staining procedure and high quantitation. In the Bradford protein assay, protein concentrations are determined by the absorbance at 595 nm due to the binding of Brilliant Blue G-250 to proteins. Brilliant Blue G-250 is a safe highly selective P2×7R antagonist with promising consequent inactivation of NLRP3 inflammasome .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108669
CAS No.: 607378-18-7
Purity:  99.93%
Target:  

P2X Receptor

Research Areas:  

Neurological Disease Cancer

AZ10606120 dihydrochloride is a selective, high affinity antagonist for P2X7 receptor (P2X7R) at human and rat with an IC50 of about 10 nM. AZ10606120 dihydrochloride is little or no effect at other P2XR subtypes. AZ10606120 dihydrochloride has anti-depressant effects and reduces tumour growth .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-100449
CAS No.: 246246-19-5
Purity:  99.00%
AL-8810 is a potent and selective antagonist of the PGF receptor (FP receptor). AL-8810 is an activator of MAPK and ERK1/2. The Ki of the FP receptor of mouse 3T3 cells and rat A7r5 cells are 0.2±0.06 μM and 0.4±0.1 μM, respectively. AL-8810 can be used in the study of elevated intraocular pressure (OHT) and primary open-angle glaucoma (POAG) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99412
CAS No.: 2375835-91-7
Synonyms: OSE-127

Target:  

Interleukin Related

Research Areas:  

Cancer

Lusvertikimab (OSE-127) is a humanized IL7R monoclonal antibody. Lusvertikimab is not internalized by target cells and prevents IL7R heterodimerization and subsequent downstream signaling. Lusvertikimab has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P990209
Anti-Mouse IL-7Rα/CD127 Antibody (A7R34) is a rat-derived IgG2a κ type antibody inhibitor, targeting to mouse IL-7Rα/CD127. Anti-Mouse IL-7Rα/CD127 Antibody (A7R34) blocks IL-7 signaling. Anti-Mouse IL-7Rα/CD127 Antibody (A7R34) can be used for the researches of cancer,infection, inflammation, immunology, cardiovascular and metabolic disease, such as abdominal aortic aneurysms, helicobacter felis-induced gastritis and diabetes .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-164426
CAS No.: 2377167-56-9
HEI3090 is a P2X7R activator. HEI3090 stimulates dendritic cells expressing P2X7R to produce IL-18, which subsequently promotes Natural Killer cells and CD4 T cells within tumors to produce IFN-γ, leading to a sustained antitumor response. HEI3090 can be used to enhance the efficacy of αPD-1 therapy in non-small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-P990774
CAS No.: 2768386-15-6
Synonyms: ASP-7266; TRAB-1; UPB-101

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Verekitug (ASP-7266; TRAB-1; UPB-101) is a human monoclonal antibody targeting the thymic stromal lymphopoietin receptor (TSLPR), with a mean half-life of approximately 20 days. At doses of Verekitug ≥100 mg, complete and sustained TSLPR-specific occupancy is achieved, and the antibody does not bind to IL-7Rα. By inhibiting TSLP-driven inflammatory responses, Verekitug blocks TSLP-induced cell proliferation and TARC expression, while reducing fractional exhaled NO levels, blood eosinophil counts, and levels of IL-5 and IgE. Verekitug significantly improves scores for nasal polyps, nasal congestion and olfactory dysfunction, with favorable safety and good tolerability; potential adverse reactions include headache, upper respiratory tract infection, sinusitis and nasopharyngitis. Verekitug is used in relevant studies on asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease .
loading...
    loading...
Cat. No.: HY-101335
CAS No.: 147782-19-2
Purity:  ≥99.0%
Target:  

mGluR

Research Areas:  

Neurological Disease

DCG-IV is a potent agonist of group II mGluRs with EC50s of 0.35 and 0.09 μM for mGlu2R and mGlu3R, reapectively. DCG-IV is also a competitive antagonist at group I (IC50: mGlu1R/5R=389/630 μM) and III receptors (IC50: mGlu4R/6R/7R/8R= 22.5/39.6/40.1/32 μM). DCG-IV has anticonvulsive and neuroprotective effects .
loading...
    loading...
Cat. No.: HY-P990023
CAS No.: 2622254-57-1
Synonyms: ADX-914

Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

Bempikibart (ADX-914) is a fully human anti-IL-7Rα antibody that re-regulates adaptive immune function by blocking signaling mediated by both IL-7 and thymic stromal lymphopoietin (TSLP). Bempikibart can be used for the study of atopic dermatitis and alopecia areata .
loading...
    loading...
Cat. No.: HY-153262
CAS No.: 2706637-12-7
Synonyms: (7R)-D3S-001
Target:  

Ras

Research Areas:  

Cancer

KRASG12C IN-2 (compound 17) is an orally active KRAS G12C inhibitor. KRASG12C IN-2 inhibits tumor growth in mice .
loading...
    loading...
Cat. No.: HY-172626
CAS No.: 2923669-28-5
Target:  

Ras

Research Areas:  

Cancer

(7R/S)-Zecdarasib is a KRAS G12D inhibitor. (7R/S)-Zecdarasib can be used in the cancer research .
loading...
    loading...
Cat. No.: HY-170784
Target:  

Transketolase Herbicide

Research Areas:  

Others

TKL-IN-1 (compound 7r) is a transketolase inhibitor and can be used as a herbicide. TKL-IN-1 can inhibit the growth of Digitaria sanguinalis (Ds) and Amaranthus retroflexus (Ar) .
loading...
    loading...
Cat. No.: HY-125378A
CAS No.: 1422180-61-7
Purity:  98.36%
Synonyms: (7R)-SBI-0636457; (7R)-SB1-0636457
Target:  

IAP

Research Areas:  

Cancer

(7R)-SBP-0636457 is the isomer of SBP-0636457 (HY-125378), and can be used as an experimental control. SBP-0636457 (SB1-0636457) is a SMAC mimetic, and as an IAP antagonist. SBP-0636457 binds to the BIR-domains of the IAP proteins, with a Ki of 0.27 μM. SBP-0636457 can be used for the research of solid tumors and hematologic cancers .
loading...
    loading...
Cat. No.: HY-N3745
CAS No.: 126253-41-6
(-)-(7R, 8S)-dihydrodehydrodiconiferyl alcohol (compound 10) is a lignan isolated from Hedyotis uncinella .
loading...
    loading...
Cat. No.: HY-N2207
CAS No.: 178740-32-4
rel-(8R,8'R)-Dimethyl-(7S,7'R)-bis(3,4-methylenedioxyphenyl)tetrahydro-furan is a chemical constituent of the fruit of Myristica fragrans.
loading...
    loading...
Cat. No.: HY-W144704B
CAS No.: 189302-44-1
(3RS, 7R, 11R)-Dihydrophytol is the hydrogenation intermediate in the synthesis of Phytanic acid (HY-113067) from Phytol (HY-N3075) .
loading...
    loading...
Cat. No.: HY-P11286
CAS No.: 632358-46-4
Target:  

Complement System

Research Areas:  

Cancer

A7RC is a multifunctional peptide used in tumor-targeted therapy, with Cysteine added to the C-terminal of the A7R peptide (sequence: ATWLPPR). A7R (HY-P1663) is a ligand of the NRP-1 receptor, regulating intracellular signal transduction related to tumor vascularization and tumor growth .
loading...
    loading...
Cat. No.: HY-174911
CAS No.: 3035801-67-0
Target:  

FLT3 Apoptosis

Research Areas:  

Cancer

FLT3-IN-33 (Compound 7r) is a FLT3 inhibitor with an IC50 of 7.82  nM. FLT3-IN-33 has superior anticancer activities against acute myeloid leukemia (AML) cells, such as MV4-11 and MOLM-13 cells. FLT3-IN-33 significantly induces cell apoptosis and inhibits phosphorylation of FLT3 pathways. FLT3-IN-33 can be used for AML and other cancers research .
loading...
    loading...